Xu L, Lan H, Su Y, Li J, & Wan J. (2015). Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: A meta-analysis. Dove Medical Press.
Chicago Style (17th ed.) CitationXu L, Lan H, Su Y, Li J, and Wan J. Clinicopathological Significance and Potential Drug Target of RUNX3 in Non-small Cell Lung Cancer: A meta-analysis. Dove Medical Press, 2015.
MLA (9th ed.) CitationXu L, et al. Clinicopathological Significance and Potential Drug Target of RUNX3 in Non-small Cell Lung Cancer: A meta-analysis. Dove Medical Press, 2015.
Warning: These citations may not always be 100% accurate.